All News

    Continuing Novel Therapeutic Research Presents New Options in Lung Cancer

    June 4th 2025, 7:00pm

    Article

    Dr. Jared Weiss details the importance of continued research into novel therapies for patients with lung cancer.

    Dealing with Insensitivity After Breast Cancer Surgery

    June 4th 2025, 5:00pm

    Article

    Breast cancer surgery can disfigure the body in some way, and often the scars are more than skin deep, which may worsen by the actions of others.

    Nubeqa Combo Positively Impacts HRQoL vs Placebo in Prostate Cancer Subgroup

    June 4th 2025, 4:00pm

    Article

    Nubeqa and ADT treatment led to positive impacts on health-related quality of life vs placebo in metastatic hormone-sensitive prostate cancer.

    Rina-S Yields 50% Response Rate in Advanced Endometrial Cancer

    June 4th 2025, 3:00pm

    Article

    Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, according to early trial findings.

    Addressing Unmet Needs for Young Women Before, During and After a Cancer Diagnosis

    June 4th 2025, 1:00pm

    Article

    Natalie Schnaitmann discusses urgent supportive care gaps that affect long-term quality of life for younger women with cancer.

    Imdelltra Shows Survival Benefit in Small Cell Lung Cancer

    June 3rd 2025, 9:00pm

    Article

    Imdelltra improved survival and quality of life versus chemotherapy as second-line treatment for small cell lung cancer, reinforcing it as a new SOC.

    Targeting ESR1 Mutations Early May Improve Outcomes in Breast Cancer

    June 3rd 2025, 8:00pm

    Video

    Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.

    FDA Approves Nubeqa in Metastatic Castration-Sensitive Prostate Cancer

    June 3rd 2025, 7:22pm

    Article

    The FDA approved Nubeqa for metastatic castration-sensitive prostate cancer based on significantly improved radiographic progression-free survival data.

    You Are Not a Statistic: Facing Cancer With Hope, Not Numbers

    June 3rd 2025, 5:00pm

    Article

    I’m here to prove that powerful phrase; after nearly 16 years living with incurable cancer, I know there’s more to my story than the statistics.

    Patritumab Deruxtecan Does Not Improve Survival Outcomes vs Chemo in EGFR+ NSCLC

    June 3rd 2025, 4:00pm

    Article

    Patritumab deruxtecan treatment did not improve suvival end points versus those treated with chemotherapy in EGFR+ advanced/metastatic NSCLC.